CDEK
← All drugs Report issue

tak-755

Recombinant proteinexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Apr 14, 2021 (NCT04683003)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05714969Phase 2Mar 21, 2023Takeda
NCT04683003Phase 3Apr 14, 2021Shire, Takeda
NCT05770219N/A—Takeda
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
TakedaFor profit3332021
ShireFor profit1012021
2 organizations
Page 1 / 1